Roberto J. Bitton, M.D. has been appointed project leader, Latin America, Kendle. In this role, he will provide medical and therapeutic expertise for Phase I-IV clinical development projects for the company’s biopharmaceutical customers, with an emphasis on oncology therapeutics. Dr. Bitton is a board-certified medical oncologist and has more than 20 years of academic, CRO and pharmaceutical industry experience. He has led clinical teams in every phase of the oncology drug development pro...